• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    More On CANF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    Can-Fite BioPharma Ltd. (CANF)

    -NYSE MKT
    5.54 Up 0.14(2.59%) Mar 27, 4:01PM EDT
    |After Hours : 5.80 Up 0.26 (4.69%) Mar 27, 7:56PM EDT
    Add to Portfolio
    Prev Close:5.40
    Open:5.15
    Bid:5.65 x 100
    Ask:6.51 x 2000
    1y Target Est:13.50
    Beta:3.55
    Next Earnings Date:N/A
    Day's Range:5.15 - 5.57
    52wk Range:2.29 - 6.24
    Volume:210,002
    Avg Vol (3m):225,855
    Market Cap:49.44M
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CANF

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.30
    Quarterly EPS Est (Dec-14) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Can-Fite BioPharma, Ltd., a clinical-stage biotechnology company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback